These results indicate that during obesity, the increase in FXR stimulates not only the assimilation of bile acids by increasing ASBT, but also the subsequent intracellular handling and export of said bile acids by augmenting the appropriate bile-acid-handling proteins such as IBABP and OSTα. The gene discussed is FABP6; the disease is obesity disorder.